| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.17▼ | 7.16▲ | 7.17▼ | 7.55▼ | 7.72▼ |
| MA10 | 7.15▲ | 7.19▼ | 7.25▼ | 7.63▼ | 7.77▼ |
| MA20 | 7.16▲ | 7.28▼ | 7.42▼ | 7.76▼ | 8.07▼ |
| MA50 | 7.22▼ | 7.53▼ | 7.61▼ | 7.71▼ | 8.05▼ |
| MA100 | 7.31▼ | 7.62▼ | 7.70▼ | 8.07▼ | 8.00▼ |
| MA200 | 7.51▼ | 7.72▼ | 7.83▼ | 8.14▼ | 7.46▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | -0.002▼ | -0.025▼ | -0.060▼ | -0.062▼ |
| RSI | 43.057▼ | 27.826▼ | 25.540▼ | 33.137▼ | 42.414▼ |
| STOCH | 77.381 | 10.799▼ | 5.828▼ | 37.263 | 35.347 |
| WILL %R | -50.000 | -91.429▼ | -92.857▼ | -96.552▼ | -98.577▼ |
| CCI | 43.036 | -66.868 | -99.816 | -265.528▼ | -116.151▼ |
|
Thursday, September 10, 2026 12:30 AM
ABOUT TG THERAPEUTICS TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/09/26 | 7.48 | 7.49 | 7.13 | 7.16 | 126,076 |
| 10/09/26 | 7.62 | 7.62 | 7.32 | 7.40 | 107,120 |
| 09/09/26 | 7.67 | 7.78 | 7.65 | 7.73 | 154,898 |
| 08/09/26 | 7.72 | 7.86 | 7.69 | 7.71 | 124,445 |
| 04/09/26 | 7.63 | 7.81 | 7.63 | 7.76 | 71,613 |
| 03/09/26 | 7.78 | 7.785 | 7.5794 | 7.66 | 68,952 |
| 02/09/26 | 7.78 | 7.87 | 7.64 | 7.66 | 88,081 |
| 01/09/26 | 7.62 | 7.77 | 7.47 | 7.71 | 169,307 |
| 31/08/26 | 7.74 | 7.80 | 7.64 | 7.69 | 120,847 |
| 28/08/26 | 7.68 | 7.82 | 7.68 | 7.80 | 101,278 |
|
|
||||
|
|
||||
|
|